Senior insider sale
Chief Executive Officer at LEXEO THERAPEUTICS, INC. — senior position signals high conviction
$133.1K
29.29K shares
What this filing means
TOWNSEND RICHARD NOLAN plans to sell 29.29K shares of LEXEO THERAPEUTICS, INC. valued at approximately $133.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/1/2026ACC: 0001959173-26-005031
DirectorOfficer· Chief Executive Officer
Since Feb 2026
29.29K
Shares to sell
$133.1K
Approx. market value
25.95K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
6/29/2026
25.95KTotal acquired25.95K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/29/2026 | Restricted Stock Vesting Compensation | 25.95K | — |
| Total | 25.95K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
3.34K
Market value
$16.9K
5/18/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
25.95K
Market value
$116.2K
7/1/2026
Total
Units
29.29K
Value
$133.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/18/2026 | 3.34K | $16.9K | — | Completed |
| Planned — Approximate Date | ||||
7/1/2026 | 25.95K | $116.2K | NASDAQ | Planned |
| Total | 29.29K | $133.1K | ||